India to Australia: Salmeterol Export Trade Route

The India to Australia Salmeterol corridor is one of India's established pharmaceutical export routes, with 52 shipments documented worth a combined $7.6M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 66% of all export value, reflecting the consolidated nature of India's salmeterol manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $146.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with salmeterol's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 23.2%, placing it at rank #8 among India's top salmeterol export destinations globally.

On the import side, key buyers of Indian salmeterol in Australia include SANDOZ PTY LTD, SANDOZ PTY LTD. SANDOZ , CIPLA AUSTRALIA PTY LTD, and 8 others. SANDOZ PTY LTD is the single largest importer with 9 shipments valued at $2.3M USD.

India's salmeterol exports to Australia are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 36 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , GNH INDIA PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $146.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as salplusf inhaler 250/25 fluticasone propionate 250 mcg + salmeterol xinafoate25 mcg inhaler and fluticasone + salmeterol cipla 250/25 hf , suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SANDOZ PTY LTD is the largest importer with 9 shipments worth $2.3M USD — representing 30% of all salmeterol imports from India on this route. A total of 11 buyers are active on this corridor.